New Step by Step Map For provigil
Reports of serious dermatologic adverse outcomes and psychiatric situations has resulted within the FDA's Pediatric Advisory Committee unanimously recommending that a specific warning versus using modafinil in youngsters be added on the company's labeling; use provided that first- and next-line solutions have unsuccessful and the advantages outweig